Cohance Lifesciences, 543064, COHANCE Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

39,932.36
149.07
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

39,921.82
N/A
23.36

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
4.75
-7.31

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
1.07
-6.95

PAT CAGR (%)

10 Years
5 Years
3 Years

-
2.24
-12.86

P:E (Median)

8 Years
5 Years
3 Years

-
34.60
40.95

P:BV (Average)

8 Years
5 Years
3 Years

-
10.28
10.34

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
34.77
40.03

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 11.8 10.52 17.79 24.09
P/E Ratio 87.84 98.53 58.26 43.03
Revenue 1036 1198 3303 4017
EBITDA 406 1081 1401
Net Income 300 268 688 933
ROA 14.2 24.1 24.8
P/B Ratio 12.83 9.64 8.19
ROE 15.86 15.13 17.83
FCFF 301 399 603
FCFF Yield 0.72 0.96 1.45
Net Debt -759 -115 -275
BVPS 80.76 107.47 126.6

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 330.17 243.52 35.58% 275.39 212.83 29.39% 236.06 224.62 5.09% 222.09 344.03 -35.44%
Expenses 262.99 171.38 53.45% 159.93 144.69 10.53% 135.05 127.27 6.11% 139.05 174.14 -20.15%
EBITDA 67.18 72.14 -6.88% 115.46 68.14 69.45% 101.01 97.35 3.76% 83.04 169.88 -51.12%
EBIDTM 20.35% 29.62% 41.93% 32.02% 42.79% 43.34% 37.39% 49.38%
Other Income 6.63 16.87 -60.70% 15.18 13.97 8.66% 13.43 14.20 -5.42% 17.95 10.06 78.43%
Interest 2.30 2.29 0.44% 2.60 1.27 104.72% 1.47 0.50 194.00% 1.60 1.15 39.13%
Depreciation 15.19 15.67 -3.06% 13.44 11.33 18.62% 12.29 10.48 17.27% 12.00 11.15 7.62%
PBT 56.32 71.05 -20.73% 114.60 69.50 64.89% 100.68 100.57 0.11% 87.39 167.65 -47.87%
Tax 11.98 17.62 -32.01% 28.25 17.14 64.82% 24.35 25.84 -5.77% 22.31 43.35 -48.54%
PAT 44.34 53.43 -17.01% 86.35 52.36 64.92% 76.33 74.73 2.14% 65.08 124.29 -47.64%
PATM 13.43% 21.94% 31.36% 24.60% 32.34% 33.27% 29.30% 36.13%
EPS 1.74 2.10 -17.14% 3.39 2.06 64.56% 3.00 2.94 2.04% 2.56 4.88 -47.54%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 402.02 252.93 58.95% 307.15 219.82 39.73% 257.72 231.05 11.54% 230.69 347.55 -33.62%
Expenses 328.46 179.59 82.89% 189.45 154.68 22.48% 153.71 133.09 15.49% 150.76 180.58 -16.51%
EBITDA 73.56 73.34 0.30% 117.70 65.14 80.69% 104.01 97.96 6.18% 79.93 166.97 -52.13%
EBIDTM 18.30% 29.00% 38.32% 29.64% 40.36% 42.40% 34.65% 48.04%
Other Income 10.57 17.05 -38.01% 15.71 14.34 9.55% 14.12 19.84 -28.83% 18.16 10.67 70.20%
Interest 5.75 2.30 150.00% 3.33 1.27 162.20% 1.67 0.50 234.00% 1.60 1.15 39.13%
Depreciation 26.78 17.25 55.25% 20.35 12.75 59.61% 16.96 11.89 42.64% 13.40 12.54 6.86%
PBT 51.60 70.85 -27.17% 109.73 65.47 67.60% 99.50 105.41 -5.61% 83.09 163.94 -49.32%
Tax 12.87 17.48 -26.37% 26.44 18.71 41.31% 17.52 25.84 -32.20% 22.32 43.35 -48.51%
PAT 38.73 53.37 -27.43% 83.29 46.75 78.16% 81.98 79.56 3.04% 60.77 120.59 -49.61%
PATM 9.63% 21.10% 27.12% 21.27% 31.81% 34.43% 26.34% 34.70%
EPS 1.65 2.10 -21.43% 3.26 1.84 77.17% 3.23 3.13 3.19% 2.39 4.74 -49.58%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 1,063.71 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83 Net Sales Growth 3.78% -22.94% 0.75% 30.75% 21.10% 120.68% Cost Of Goods Sold 280.48 298.62 394.26 394.05 297.56 225.32 101.46 Gross Profit 783.23 726.38 935.83 926.17 712.16 608.47 276.37 GP Margin 73.63% 70.87% 70.36% 70.15% 70.53% 72.98% 73.15% Total Expenditure 697.02 615.09 739.39 737.94 566.68 449.00 206.28 Power & Fuel Cost - 46.16 71.35 59.55 44.20 38.23 18.06 % Of Sales - 4.50% 5.36% 4.51% 4.38% 4.59% 4.78% Employee Cost - 126.88 108.58 100.48 76.23 65.10 29.63 % Of Sales - 12.38% 8.16% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 85.49 106.75 129.24 105.31 83.89 35.11 % Of Sales - 8.34% 8.03% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 32.97 31.13 28.43 27.69 25.93 12.62 % Of Sales - 3.22% 2.34% 2.15% 2.74% 3.11% 3.34% Selling & Distn. Exp. - 10.35 17.43 19.80 10.53 9.43 6.72 % Of Sales - 1.01% 1.31% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 14.63 9.90 6.37 5.16 1.08 2.69 % Of Sales - 1.43% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 366.69 409.90 590.69 582.28 443.04 384.79 171.55 EBITDA Margin 34.47% 39.99% 44.41% 44.10% 43.88% 46.15% 45.40% Other Income 53.19 55.09 44.55 187.79 14.24 18.12 0.60 Interest 7.97 7.43 12.75 8.53 11.66 21.81 2.79 Depreciation 52.92 48.79 43.10 39.10 31.64 23.51 11.50 PBT 358.99 408.77 579.39 722.45 413.98 357.59 157.87 Tax 86.89 103.96 146.79 164.35 105.33 87.51 48.59 Tax Rate 24.20% 25.43% 25.34% 22.75% 25.44% 24.47% 30.78% PAT 272.10 304.82 432.60 558.10 308.65 270.08 109.27 PAT before Minority Interest 272.10 304.82 432.60 558.10 308.65 270.08 109.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 25.58% 29.74% 32.52% 42.27% 30.57% 32.39% 28.92% PAT Growth -10.73% -29.54% -22.49% 80.82% 14.28% 147.17% EPS 10.69 11.97 16.99 21.92 12.12 10.61 4.29

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 1,197.58 1,051.35 1,340.33 1,320.22 1,009.72 833.79 377.83 Net Sales Growth 13.91% -21.56% 1.52% 30.75% 21.10% 120.68% Cost Of Goods Sold 305.29 311.39 402.97 394.05 297.56 225.32 101.46 Gross Profit 892.29 739.97 937.36 926.17 712.16 608.47 276.37 GP Margin 74.51% 70.38% 69.94% 70.15% 70.53% 72.98% 73.15% Total Expenditure 822.38 645.54 766.17 738.50 566.72 449.03 206.28 Power & Fuel Cost - 48.30 73.93 59.55 44.20 38.23 18.06 % Of Sales - 4.59% 5.52% 4.51% 4.38% 4.59% 4.78% Employee Cost - 135.92 118.25 100.48 76.23 65.10 29.63 % Of Sales - 12.93% 8.82% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 89.05 109.62 129.24 105.31 83.89 35.11 % Of Sales - 8.47% 8.18% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 35.90 33.87 28.99 27.73 25.97 12.62 % Of Sales - 3.41% 2.53% 2.20% 2.75% 3.11% 3.34% Selling & Distn. Exp. - 10.35 17.64 19.80 10.53 9.43 6.72 % Of Sales - 0.98% 1.32% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 14.63 9.90 6.37 5.16 1.08 2.69 % Of Sales - 1.39% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 375.20 405.81 574.16 581.72 443.00 384.76 171.55 EBITDA Margin 31.33% 38.60% 42.84% 44.06% 43.87% 46.15% 45.40% Other Income 58.56 61.91 46.36 92.38 14.24 18.12 0.60 Interest 12.35 7.45 12.81 8.53 11.67 23.07 2.79 Depreciation 77.49 54.60 47.99 39.10 31.64 23.51 11.50 PBT 343.92 405.67 559.73 626.48 413.94 356.30 157.87 Tax 79.15 105.39 148.44 213.78 105.33 87.51 48.59 Tax Rate 23.01% 25.98% 26.52% 34.12% 25.45% 24.56% 30.78% PAT 264.77 300.28 411.29 453.80 308.61 268.79 109.27 PAT before Minority Interest 267.87 300.28 411.29 453.80 308.61 268.79 109.27 Minority Interest 3.10 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.11% 28.56% 30.69% 34.37% 30.56% 32.24% 28.92% PAT Growth -11.82% -26.99% -9.37% 47.05% 14.81% 145.99% EPS 10.40 11.79 16.15 17.82 12.12 10.56 4.29

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 2,055.90 1,749.38 1,520.69 1,065.18 782.83 590.29 Share Capital 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 2,028.45 1,723.92 1,495.24 1,039.73 770.10 577.56 Non-Current Liabilities 79.38 54.77 75.19 73.91 127.68 35.12 Secured Loans 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 10.01 7.87 8.89 6.65 8.31 5.95 Current Liabilities 203.58 298.50 346.23 321.49 319.85 190.67 Trade Payables 41.27 66.89 105.90 82.93 71.06 53.57 Other Current Liabilities 20.95 18.53 28.25 28.56 27.51 19.47 Short Term Borrowings 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 102.79 148.48 144.94 104.36 127.24 34.83 Total Liabilities 2,338.86 2,102.65 1,942.11 1,460.58 1,230.36 816.08 Net Block 523.54 512.03 534.19 441.16 356.74 270.90 Gross Block 764.20 713.00 693.81 569.62 456.66 347.41 Accumulated Depreciation 240.66 200.98 159.62 128.46 99.91 76.51 Non Current Assets 1,031.16 1,003.21 695.93 794.13 719.36 393.28 Capital Work in Progress 179.08 164.81 29.99 96.32 101.71 111.07 Non Current Investment 317.21 317.21 118.67 245.65 245.65 0.07 Long Term Loans & Adv. 11.33 9.16 13.07 10.85 15.06 11.02 Other Non Current Assets 0.00 0.00 0.00 0.16 0.20 0.22 Current Assets 1,307.69 1,099.44 1,246.19 666.45 511.00 422.80 Current Investments 767.45 392.85 481.22 180.59 30.67 7.06 Inventories 220.07 311.47 283.42 201.08 174.87 157.10 Sundry Debtors 126.97 109.66 236.37 102.38 117.20 147.50 Cash & Bank 21.58 46.23 32.95 9.56 13.96 12.90 Other Current Assets 171.63 10.73 9.15 56.03 174.30 98.24 Short Term Loans & Adv. 160.25 228.50 203.08 116.80 134.56 37.32 Net Current Assets 1,104.11 800.94 899.96 344.96 191.15 232.13 Total Assets 2,338.85 2,102.65 1,942.12 1,460.58 1,230.36 816.08

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 2,050.66 1,735.18 1,527.18 1,180.81 844.76 590.29 Share Capital 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 2,023.21 1,709.73 1,501.72 1,155.35 832.03 577.56 Non-Current Liabilities 96.53 71.79 92.11 73.91 127.68 35.12 Secured Loans 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 10.50 8.30 8.89 6.65 8.31 5.95 Current Liabilities 206.06 303.09 347.52 321.51 319.85 190.67 Trade Payables 42.36 70.09 105.90 82.93 71.06 53.57 Other Current Liabilities 21.22 19.84 29.54 28.57 27.51 19.47 Short Term Borrowings 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 103.90 148.56 144.94 104.36 127.24 34.83 Total Liabilities 2,353.25 2,110.06 1,966.81 1,576.23 1,292.29 816.08 Net Block 669.62 663.33 534.19 441.16 356.74 270.90 Gross Block 927.38 875.60 693.81 569.62 456.66 347.41 Accumulated Depreciation 257.76 212.27 159.62 128.46 99.91 76.51 Non Current Assets 990.90 954.70 701.66 909.68 781.17 393.28 Capital Work in Progress 179.08 165.09 29.99 96.32 101.71 111.07 Non Current Investment 130.58 117.10 117.10 361.19 307.46 0.07 Long Term Loans & Adv. 11.41 9.19 13.07 10.85 15.06 11.02 Other Non Current Assets 0.20 0.00 7.30 0.16 0.20 0.22 Current Assets 1,362.35 1,155.37 1,265.16 666.54 511.12 422.80 Current Investments 773.90 418.94 481.22 180.59 30.67 7.06 Inventories 231.20 312.81 283.42 201.08 174.87 157.10 Sundry Debtors 133.66 110.94 236.37 102.38 117.20 147.50 Cash & Bank 50.50 68.01 47.31 9.65 14.07 12.90 Other Current Assets 173.09 11.46 9.15 56.03 174.30 98.24 Short Term Loans & Adv. 161.19 233.21 207.69 116.80 134.56 37.32 Net Current Assets 1,156.29 852.28 917.64 345.04 191.27 232.13 Total Assets 2,353.25 2,110.07 1,966.82 1,576.22 1,292.29 816.08

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 370.65 492.82 269.89 328.84 358.75 50.40 PBT 408.77 579.39 722.45 413.98 357.59 157.87 Adjustment 10.22 35.68 -110.18 36.48 33.35 13.93 Changes in Working Capital 60.17 23.53 -190.63 -12.19 54.22 -88.33 Cash after chg. in Working capital 479.17 638.61 421.64 438.27 445.16 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -108.52 -145.79 -151.74 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -381.58 -236.86 -90.30 -257.66 -366.65 -65.48 Net Fixed Assets -65.47 -154.01 -57.86 -107.57 -99.89 Net Investments -374.60 -110.17 -173.65 -149.92 -269.19 Others 58.49 27.32 141.21 -0.17 2.43 Cash from Financing Activity -13.78 -243.14 -156.48 -75.66 8.58 25.98 Net Cash Inflow / Outflow -24.71 12.81 23.12 -4.49 0.67 10.90 Opening Cash & Equivalents 43.02 30.21 7.09 11.58 10.90 0.00 Closing Cash & Equivalent 18.31 43.02 30.21 7.09 11.58 10.90

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 358.48 457.20 330.00 382.55 406.92 50.40 PBT 405.67 559.73 667.59 467.67 404.51 157.87 Adjustment 15.35 37.46 40.63 36.48 34.60 13.93 Changes in Working Capital 47.41 5.77 -193.97 -12.17 54.21 -88.33 Cash after chg. in Working capital 468.43 602.96 514.26 491.98 493.33 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -109.95 -145.76 -184.26 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -362.25 -195.01 -136.14 -311.40 -413.45 -65.48 Net Fixed Assets -65.47 -154.01 -57.86 -107.57 -99.89 Net Investments -374.60 -110.17 -173.65 -149.92 -269.19 Others 77.82 69.17 95.37 -53.91 -44.37 Cash from Financing Activity -13.80 -241.95 -156.48 -75.66 7.32 25.98 Net Cash Inflow / Outflow -17.57 20.24 37.38 -4.51 0.79 10.90 Opening Cash & Equivalents 64.80 44.56 7.18 11.70 10.90 0.00 Closing Cash & Equivalent 47.23 64.80 44.56 7.18 11.70 10.90

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 80.68 68.72 59.74 41.84 30.75 0.00 ROA 13.73% 21.39% 32.80% 22.94% 26.40% 13.39% ROE 16.03% 26.46% 43.17% 33.40% 39.71% 18.92% ROCE 21.27% 34.48% 51.79% 39.15% 46.23% 23.87% Fixed Asset Turnover 1.39 1.89 2.09 1.97 2.07 1.09 Receivable days 42.13 47.44 46.80 39.69 57.94 142.49 Inventory Days 94.64 81.55 66.93 67.95 72.66 151.76 Payable days 66.10 79.99 87.45 94.44 49.88 86.75 Cash Conversion Cycle 70.67 49.01 26.27 13.19 80.72 207.50 Total Debt/Equity 0.02 0.04 0.06 0.13 0.24 0.14 Interest Cover 56.04 46.45 85.72 36.49 17.39 57.60

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 80.48 68.16 59.99 46.39 33.18 0.00 ROA 13.46% 20.18% 25.62% 21.52% 25.50% 13.39% ROE 15.87% 25.21% 33.52% 30.47% 37.80% 18.92% ROCE 21.22% 33.41% 45.92% 36.19% 44.55% 23.87% Fixed Asset Turnover 1.17 1.71 2.09 1.97 2.07 1.09 Receivable days 42.46 47.25 46.80 39.69 57.94 142.49 Inventory Days 94.43 81.11 66.93 67.95 72.66 151.76 Payable days 65.90 79.70 87.45 94.44 49.88 86.75 Cash Conversion Cycle 70.98 48.66 26.27 13.19 80.72 207.50 Total Debt/Equity 0.02 0.04 0.06 0.12 0.22 0.14 Interest Cover 55.44 44.69 79.29 36.48 16.45 57.60

Top Investors:

jasti property and equity holdings private limited

dsp regular savings fund

sbi life insurance co. ltd

invesco india contra fund

goldman sachs funds - goldman sachs india equity p

hsbc midcap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Cohance Lifesciences enters into agreements with Chromo Laboratories India
20th Jun 2025, 15:00 PM

The said transaction is expected to be completed in Q2 FY26, subject to satisfaction of customary closing conditions under the said agreements
Read More
Cohance Lifesciences receives EIR from USFDA for API Unit-IV in Telangana
26th May 2025, 09:37 AM

The inspection was classified as VAI and indicates the formal closure of the inspection process by the USFDA
Read More

Cohance Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

BSE: 543064 | NSE: COHANCE

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Cohance Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

BSE: 543064 | NSE: COHANCE

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: